Pamidronate for Hypercalcemia in Critically Ill Surgical Patients
Lisa Hall Zimmerman, Heather S Dolman, Lauren Riley Howell, Janie Faris, William B Zimmerman, Alfred E Baylor, James Tyburski, Robert F Wilson · 2024
Read Pamidronate for Hypercalcemia in Critically Ill Surgical Patients by Lisa Hall Zimmerman, Heather S Dolman, Lauren Riley Howell, Janie Faris, William B Zimmerman, Alfred E Baylor, James Tyburski, Robert F Wilson (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11613966.txt.
Description
Lisa Hall Zimmerman and co-authors reviewed in 2024 a drug used for high blood calcium in very ill surgical patients. High calcium in such patients tracks with worse illness and higher death rates. The study looked back at thirty patients in surgical intensive care over three years, matched by age and illness score.
Within four days of the drug, blood calcium fell to a near normal range, and most cases were corrected. Kidney markers rose, though, in patients whose kidneys were already weak. A higher calcium level at the start was tied to much higher death rates. The authors see benefit for calcium control, with care needed where kidney function is poor.
Catalog record
| CREATOR | Lisa Hall Zimmerman, Heather S Dolman, Lauren Riley Howell, Janie Faris, William B Zimmerman, Alfred E Baylor, James Tyburski, Robert F Wilson |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |